Advertisement

Topics

New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical ...

23:00 EDT 7 Sep 2017 | BioMedReports - Blog
  • Phase 2 Interim Analysis Data Presented at ESMO 2017 Congress

SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 08, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical ...

NEXT ARTICLE

More From BioPortfolio on "New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical ..."

Quick Search
Advertisement